Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy
- 1 June 1994
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 120 (6) , 378-381
- https://doi.org/10.1007/bf01247465
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Overexpression of the Oncogene c-erb B2 in Primary Ovarian CancerInternational Journal of Gynecological Pathology, 1994
- Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- c-erbB-2-Onkogenüberexpression bei primären Ovarialkarzinomen: Häufigkeit und prognostische Bedeutung bei 243 PatientinnenGeburtshilfe und Frauenheilkunde, 1992
- c‐erbB‐2 oncogene expression in ovarian cancerThe Journal of Pathology, 1990
- In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma CellsJapanese Journal of Cancer Research, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Human squamous cell lung cancers express increased epidermal growth factor receptors.Journal of Clinical Investigation, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981